deltatrials

Gladwin, Mark, MD Clinical Trials

Sponsors / Gladwin, Mark, MD

Gladwin, Mark, MD is listed as the lead sponsor on 10 clinical trials registered with ClinicalTrials.gov. 0 trials are actively recruiting participants, 0 remain active without open enrollment, and 7 have concluded. 3 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include funding constraints, slow or insufficient recruitment. The cumulative planned enrollment figure across all listed trials is 235 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.

10
Total Trials
0
Recruiting
0
Other Active
7
Completed
3
Terminated / Withdrawn
235
Total Enrollment

Termination reasons: Other33% · Funding33% · Recruitment33%

Recent Terminations

  • NCT03364686 Phase PHASE2 Stopped Jun 2021
    Healthy Volunteers
    "Due to enrollment challenges related to COVID and lack of coordinator support"
  • NCT01715883 Phase PHASE2 Stopped May 2017
    Primary Graft Dysfunction
    "Lack of support staff"
  • NCT01848301 Phase PHASE1 Stopped May 2017
    Antibody Mediated Rejection
    "loss of funding"

Top Conditions

Top Locations